Cheniere Energy vs Medtronic PLC — how do they compare? Cheniere Energy trades at $278.18 (market cap $57.39B), while Medtronic PLC trades at $88.48 (market cap $112.24B). The key difference: Medtronic PLC is the larger of the two by market cap, and Medtronic PLC pays the higher dividend (3.28%). Which is the better fit depends on your goals — on Pluang, investors hold Cheniere Energy for 10 Days and Medtronic PLC for 63 Days on average.
| LNG | MDT | |
|---|---|---|
Market Cap | $57.39B | $112.24B |
Volume | 1,215,835 | 105,663,236 |
Sector | Energy | Health |
52-Week High | $296.91 | $105.35 |
52-Week Low | $188.83 | $73.75 |
Typical Hold Time | 10 Days | 63 Days |
Enterprise Value | $82.85B | $131.58B |
Dividend Yield | 0.8% | 3.28% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Medtronic (MDT) trades at $87.75, up 2.62% today, with strong analyst support (60.8% buy ratings) and a $97.80 consensus price target suggesting 11.5% upside. The stock shows consistent earnings beats in recent quarters and maintains a 49-year dividend growth streak. However, technical indicators signal bearish momentum with resistance near $89-90. Revenue growth accelerated to $33.54B in 2025 with net margins improving to 13.93%, though debt levels have risen to 31.1% of assets.
MDT presents a compelling value opportunity with attractive dividend yield and earnings momentum, but faces near-term technical headwinds and increasing leverage. The upcoming Q3 earnings report and MiniMed separation will be critical catalysts. Investors should weigh the strong fundamental recovery against bearish technical signals and monitor debt management closely.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Cheniere Energy produces, liquefies, and exports natural gas as liquefied natural gas, or LNG. It operates large-scale LNG infrastructure along the U.S. Gulf Coast.
Read more on LNG →One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →